Medicine and Dentistry
Patient
100%
Neoplasm
71%
Therapeutic Procedure
51%
Clear Cell Renal Cell Carcinoma
45%
Bladder Cancer
41%
Prostate Cancer
35%
Cells
30%
Cancer Cell
25%
Tissues
24%
Gene
23%
Malignant Neoplasm
23%
Partial Nephrectomy
23%
Kidney
23%
Sodium Valproate
22%
Adenoviridae
21%
Analysis
21%
Kidney Tumour
20%
Lesion
19%
Follow up
19%
Complication
18%
Biopsy
17%
Survival
17%
Mortality
17%
Radical Nephrectomy
16%
Gene Therapy
15%
Metastatic Carcinoma
14%
Combination Therapy
14%
Androgen Receptor
13%
Prostate Specific Membrane Antigen
13%
Promoter Region
13%
Bleeding
13%
Tumor Thrombus
13%
Recurrent Disease
13%
Surgery
12%
Enhancer Region
12%
Hazard Ratio
12%
Stromal Tumor
12%
Diseases
11%
Development
11%
In Vitro
11%
Diagnosis
11%
Coxsackie Virus and Adenovirus Receptor
11%
Inferior Vena Cava
11%
Histone Deacetylase Inhibitor
10%
Predictor
10%
Inpatient
10%
Transitional Cell Carcinoma
10%
Computer Assisted Tomography
9%
N (4 Methoxyphenylacetyl)dehydroalanine
9%
Overall Survival
9%
Biochemistry, Genetics and Molecular Biology
Androgen Receptor
38%
Nested Gene
32%
Cancer Cell
29%
Adenoviridae
24%
Promoter Region
18%
Development
12%
Luciferase
12%
Enhancer Region
12%
Progesterone Receptor
12%
Virus
10%
Peptide
9%
P21
9%
Gene Therapy
9%
Growth
9%
Chicken
8%
Radiation
8%
Stem Cell
8%
DNA
8%
Sample
7%
Polyadenylation
6%
Virus Replication
6%
Fibrinogen Blood Level
6%
Time
6%
Transfer Gene
6%
Response Element
6%
MicroRNA
6%
Prostate-Specific Antigen
5%
Transcription
5%
Electric Potential
5%
Angiogenesis
5%
Diphtheria Toxin
5%
NAD(P)H Oxidase
5%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
34%
Bladder Cancer
25%
Sodium Valproate
22%
Adenoviridae
16%
Androgen Receptor
15%
Prostate Specific Antigen
12%
Oncolytic Adenovirus
10%
Histone Deacetylase Inhibitor
8%
Neoplasm
7%
Radiation
7%
Western Blot
7%
Mouse
6%
Hormone
6%
N (4 Methoxyphenylacetyl)dehydroalanine
5%
Toxicity
5%
Virus
5%
Prostate Stem Cell Antigen
5%
Androgen
5%
